Bioventus Inc Cl A (BVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Sales | 340,141 | 319,177 | 319,177 | 0 |
| Cost of Goods | 90,935 | 84,168 | 84,168 | N/A |
| Gross Profit | 249,206 | 235,009 | 235,009 | N/A |
| Operating Expenses | 218,948 | 209,673 | 209,673 | 0 |
| Operating Income | 31,193 | 25,504 | 25,504 | N/A |
| Interest Expense | 21,579 | 19,171 | 19,171 | 0 |
| Other Income | 75 | -226 | -226 | 0 |
| Pre-tax Income | 9,689 | 6,107 | 6,107 | 0 |
| Income Tax | 1,576 | 1,664 | 1,664 | N/A |
| Net Income Continuous | 8,113 | 4,443 | 4,443 | N/A |
| Net Income Discontinuous | -1,815 | -16,650 | -16,650 | N/A |
| Minority Interests | -553 | N/A | N/A | N/A |
| Net Income | $6,851 | $-12,207 | $-12,207 | $N/A |
| EPS Basic Total Ops | N/A | -3.67 | -3.67 | N/A |
| EPS Basic Continuous Ops | N/A | -0.27 | -0.27 | N/A |
| EPS Basic Discontinuous Ops | N/A | 3.40 | 3.40 | N/A |
| EPS Diluted Total Ops | N/A | -3.67 | -3.67 | N/A |
| EPS Diluted Continuous Ops | N/A | -0.27 | -0.27 | N/A |
| EPS Diluted Discontinuous Ops | N/A | 3.40 | 3.40 | N/A |
| EBITDA(a) | $61,509 | $56,428 | $25,504 | $N/A |